Insider Transactions in Q1 2026 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,500
-46.83%
|
$1,200,000
$800.0 P/Share
|
|
Jan 07
2026
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+31.89%
|
$561,000
$374.12 P/Share
|
|
Jan 02
2026
|
Huda Y Zoghbi Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+8.34%
|
-
|
|
Jan 02
2026
|
Kathryn Guarini Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+20.45%
|
-
|
|
Jan 02
2026
|
George L Sing Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.5%
|
-
|
|
Jan 02
2026
|
Craig B. Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+16.67%
|
-
|
|
Jan 02
2026
|
Michael S Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+8.34%
|
-
|
|
Jan 02
2026
|
N Anthony Coles Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+8.29%
|
-
|
|
Jan 02
2026
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.86%
|
-
|
|
Jan 02
2026
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+2.26%
|
-
|
|
Jan 02
2026
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+20.45%
|
-
|
|
Jan 02
2026
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+8.34%
|
-
|
|
Jan 02
2026
|
Christine A Poon Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+2.88%
|
-
|